Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs

David M Shackleford; W A (Fried) Faassen; Natalie Houwing; Holger Lass; Glenn A Edwards; Christopher John H Porter; William N Charman

doi:10.1124/jpet.103.052522

Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs

David M Shackleford, W A (Fried) Faassen, Natalie Houwing, Holger Lass, Glenn A Edwards, Christopher John H Porter, William N Charman

Drug Delivery Disposition & Dynamics

Research output: Contribution to journal › Article › Research › peer-review

98 Citations (Scopus)

Original language	English
Pages (from-to)	925 - 933
Number of pages	9
Journal	Journal of Pharmacology and Experimental Therapeutics
Volume	306
Issue number	3
DOIs	https://doi.org/10.1124/jpet.103.052522
Publication status	Published - 2003

Access to Document

10.1124/jpet.103.052522

Cite this

Shackleford, D. M., Faassen, W. A., Houwing, N., Lass, H., Edwards, G. A., Porter, C. J. H., & Charman, W. N. (2003). Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs. Journal of Pharmacology and Experimental Therapeutics, 306(3), 925 - 933. https://doi.org/10.1124/jpet.103.052522

Shackleford, David M ; Faassen, W A (Fried) ; Houwing, Natalie et al. / Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs. In: Journal of Pharmacology and Experimental Therapeutics. 2003 ; Vol. 306, No. 3. pp. 925 - 933.

@article{50d865a9436d4c65b83c597c2f832c09,

title = "Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs",

author = "Shackleford, {David M} and Faassen, {W A (Fried)} and Natalie Houwing and Holger Lass and Edwards, {Glenn A} and Porter, {Christopher John H} and Charman, {William N}",

year = "2003",

doi = "10.1124/jpet.103.052522",

language = "English",

volume = "306",

pages = "925 -- 933",

journal = "Journal of Pharmacology and Experimental Therapeutics",

issn = "0022-3565",

publisher = "American Society for Pharmacology & Experimental Therapeutics (ASPET)",

number = "3",

}

Shackleford, DM, Faassen, WA, Houwing, N, Lass, H, Edwards, GA, Porter, CJH & Charman, WN 2003, 'Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs', Journal of Pharmacology and Experimental Therapeutics, vol. 306, no. 3, pp. 925 - 933. https://doi.org/10.1124/jpet.103.052522

Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs. / Shackleford, David M; Faassen, W A (Fried); Houwing, Natalie et al.
In: Journal of Pharmacology and Experimental Therapeutics, Vol. 306, No. 3, 2003, p. 925 - 933.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs

AU - Shackleford, David M

AU - Faassen, W A (Fried)

AU - Houwing, Natalie

AU - Lass, Holger

AU - Edwards, Glenn A

AU - Porter, Christopher John H

AU - Charman, William N

PY - 2003

Y1 - 2003

U2 - 10.1124/jpet.103.052522

DO - 10.1124/jpet.103.052522

M3 - Article

SN - 0022-3565

VL - 306

SP - 925

EP - 933

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

IS - 3

ER -

Shackleford DM, Faassen WA, Houwing N, Lass H, Edwards GA, Porter CJH et al. Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs. Journal of Pharmacology and Experimental Therapeutics. 2003;306(3):925 - 933. doi: 10.1124/jpet.103.052522